It has been reported that change in serum AFP level could be used to assess HB patient responsiveness to chemotherapy, and the log-fold change in AFP during chemotherapy was a predictive factor for survival in HB patients underwent LT (12, 16–18). Here, AFP is linked to hemoglobin measurement.